Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xianling Gubao after hip-preserving surgery for early osteonecrosis of the femoral head
ChiCTR2100043127Phase 4Recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Jan 2021
- Countries
- 1
01
Overview
Phase 4, randomised trial of xianlinggubao in osteonecrosis of the hip (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoints: X-rays, CT scans and 3 more. Started Jan 2021; status: recruiting.
02
Drugs
xianlinggubao
03
Conditions
osteonecrosis of the hip
Beyond the preview
Go deeper on ChiCTR2100043127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043127.